USPTO Patent Application: Compositions for Mitochondrial Health
Summary
The USPTO has published a patent application (US20260083747A1) detailing compositions for supporting mitochondrial health using methylthioninium salts combined with other compounds. The application was filed on October 30, 2024, by inventors Darren Lopez and Dan Schmidt.
What changed
This document is a USPTO patent application (US20260083747A1) for novel compositions designed to support mitochondrial health. The application describes specific formulations containing methylthioninium salts combined with other mitochondria-enhancing compounds such as urolithin A, pyrroloquinoline quinone, or tesofensine, detailing precise weight ratios for these combinations. The filing date for this application was October 30, 2024.
As this is a patent application, it does not impose immediate compliance obligations on regulated entities. However, it signifies potential future developments in the pharmaceutical and biotechnology sectors. Companies involved in drug development, particularly those focusing on metabolic health or aging, should be aware of this filing for competitive intelligence and potential intellectual property considerations. No compliance actions or deadlines are associated with patent applications themselves.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS FOR SUPPORTING MITOCHONDRIAL HEALTH
Application US20260083747A1 Kind: A1 Mar 26, 2026
Inventors
Darren LOPEZ, Dan SCHMIDT
Abstract
Methylthioninium salt-containing compositions can include a methylthioninium salt and a second mitochondria-enhancing compound selected from urolithin A having a methylthioninium salt to urolithin A weight ratio from about 1:600 to about 1:4, pyrroloquinoline quinone having a methylthioninium salt to pyrroloquinoline quinone weight ratio from about 1:20 to about 50:1, tesofensine having a methylthioninium salt to tesofensine weight ratio from about 1:2 to about 100:1, or a combination thereof.
CPC Classifications
A61K 31/5415 A61K 9/0053 A61K 31/352 A61K 31/439 A61K 31/4745 A61P 3/00
Filing Date
2024-10-30
Application No.
18931346
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.